Home › NDC Lookup › RxCUI directory › RxCUI 1088126

Tetrahydrozoline hydrochloride 0.5 MG/ML Ophthalmic Solution [Visine] — RxCUI 1088126

Name: Tetrahydrozoline hydrochloride 0.5 MG/ML Ophthalmic Solution [Visine] (RxCUI 1088126)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 1088126 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1088126

Official nameTetrahydrozoline hydrochloride 0.5 MG/ML Ophthalmic Solution [Visine]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asVisine 0.5 MG/ML Ophthalmic Solution; Visine 0.05 % Ophthalmic Solution; Visine Original 0.05 % Ophthalmic Solution

FDA products mapped1

Package NDCs mapped1

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Tetrahydrozoline Ophthalmic: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

It relieves the redness you see, but it doesn't treat the underlying cause of the irritation. Think of it as a short-term fix to take the red out. If something is genuinely botheri...
What exactly does this eye drop do — does it actually fix what's irritating my eye?
No — you should remove your contact lenses before putting in the drops. The solution can be absorbed by soft contacts, which can affect the lens and potentially irritate your eye....
Can I wear my contact lenses while using these drops?

📖 Read our full Tetrahydrozoline Ophthalmic guide →

🕸️ Concept Web — How Tetrahydrozoline hydrochloride 0.5 MG/ML Ophthal... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Tetrahydrozoline hydrochloride 0.5 MG/ML Ophthalmic Solution [Visine] RxCUI 1088126 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Tetrahydrozoline 37935 IN
- Tetrahydrozoline hydrochloride 57983 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Visine 227581 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Tetrahydrozoline Ophthalmic Solution 374067 SCDF
- Tetrahydrozoline hydrochloride Ophthalmic Solution 2648819 SCDFP
- Tetrahydrozoline Ophthalmic Product 1161510 SCDG
- Tetrahydrozoline hydrochloride Ophthalmic Product 2663077 SCDGP
- Tetrahydrozoline Ophthalmic Solution [Visine] 363874 SBDF
- Tetrahydrozoline hydrochloride Ophthalmic Solution [Visine] 2654785 SBDFP
- Visine Ophthalmic Product 1187003 SBDG
- Ophthalmic Solution 7670 DF
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Tetrahydrozoline hydrochloride 0.5 MG/ML Ophthalmic Solution 1052943 SCD
- Tetrahydrozoline hydrochloride 0.5 MG/ML 996200 SCDC
- Tetrahydrozoline hydrochloride 0.5 MG/ML [Visine] 1088125 SBDC

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Tetrahydrozoline hydrochloride 0.5 MG/ML Ophthalmic Solution SCD · 1052943
Tetrahydrozoline hydrochloride 0.5 MG/ML SCDC · 996200
Tetrahydrozoline Ophthalmic Solution SCDF · 374067
Tetrahydrozoline hydrochloride Ophthalmic Solution SCDFP · 2648819
Tetrahydrozoline Ophthalmic Product SCDG · 1161510
Tetrahydrozoline hydrochloride Ophthalmic Product SCDGP · 2663077

Brand-Name Concepts

Tetrahydrozoline hydrochloride 0.5 MG/ML [Visine] SBDC · 1088125
Tetrahydrozoline Ophthalmic Solution [Visine] SBDF · 363874
Tetrahydrozoline hydrochloride Ophthalmic Solution [Visine] SBDFP · 2654785
Visine Ophthalmic Product SBDG · 1187003
Visine BN · 227581

📦 FDA Products & Package NDCs

1 product · 1 package NDC

1 package NDC map to RxCUI 1088126 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
69968-0355-01	1 BOTTLE, DROPPER in 1 CARTON (69968-0355-1) / 15 mL in 1 B...	Visine Red Eye Comfort	Kenvue Brands LLC	2020-04-27

Observed labelers: Kenvue Brands LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.